Unpacking Q3 Earnings: Skechers (NYSE:SKX) In The Context Of Other Footwear Stocks Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Skechers (NYSE:SKX) and the best and worst performers in the footwear industry. Before the advent of the internet, styles changed, but consumers mainly bought shoes by visiting local brick-and-mortar shoe, department, and specialty stores. Today, not only do styles change more frequently as fads travel through social media and the internet but consumers are also shifting the way they buy their goods, favoring omnichannel and e-commerce experiences. Some footwear companies have made concerted efforts to adapt while those who are slower to move may fall behind. The 8 footwear stocks we track reported a strong Q3. As a group, revenues beat analysts’ consensus estimates by 2.7% while next quarter’s revenue guidance was 1.2% below. Thankfully, share prices of the companies have been resilient as they are up 5.9% on average since the latest earnings results. Skechers (NYSE:SKX) Synonymous with "dad shoe", Skechers (NYSE:SKX) is a footwear company renowned for its comfortable, stylish, and affordable shoes for all ages. Skechers reported revenues of $2.35 billion, up 15.9% year on year. This print exceeded analysts’ expectations by 1.8%. Despite the top-line beat, it was still a mixed quarter for the company with a solid beat of analysts’ constant currency revenue estimates but a miss of analysts’ adjusted operating income estimates.Skechers Total Revenue Interestingly, the stock is up 19.2% since reporting and currently trades at $73.46. Is now the time to buy Skechers? Access our full analysis of the earnings results here, it’s free. Best Q3: Genesco (NYSE:GCO) Spanning a broad range of styles, brands, and prices, Genesco (NYSE:GCO) sells footwear, apparel, and accessories through multiple brands and banners. Genesco reported revenues of $596.3 million, up 2.9% year on year, outperforming analysts’ expectations by 3.2%. The business had a stunning quarter with a solid beat of analysts’ EPS estimates and an impressive beat of analysts’ adjusted operating income estimates.Genesco Total Revenue The market seems happy with the results as the stock is up 25.5% since reporting. It currently trades at $46.99. Is now the time to buy Genesco? Access our full analysis of the earnings results here, it’s free. Weakest Q3: Caleres (NYSE:CAL) The owner of Dr. Scholl's, Caleres (NYSE:CAL) is a footwear company offering a range of styles. Caleres reported revenues of $740.9 million, down 2.8% year on year, falling short of analysts’ expectations by 1.4%. It was a softer quarter as it posted full-year EPS guidance missing analysts’ expectations significantly and a miss of analysts’ EPS estimates. Story Continues Caleres delivered the weakest performance against analyst estimates in the group. As expected, the stock is down 40.5% since the results and currently trades at $19.77. Read our full analysis of Caleres’s results here. Crocs (NASDAQ:CROX) Founded in 2002, Crocs (NASDAQ:CROX) sells casual footwear and is known for its iconic clog shoe. Crocs reported revenues of $1.06 billion, up 1.6% year on year. This print topped analysts’ expectations by 1%. Aside from that, it was a mixed quarter as it also produced an impressive beat of analysts’ constant currency revenue estimates but EPS guidance for next quarter missing analysts’ expectations significantly. The stock is down 25.7% since reporting and currently trades at $102.64. Read our full, actionable report on Crocs here, it’s free. Steven Madden (NASDAQ:SHOO) As seen in the infamous Wolf of Wall Street movie, Steven Madden (NASDAQ:SHOO) is a fashion brand famous for its trendy and innovative footwear, appealing to a young and style-conscious audience. Steven Madden reported revenues of $624.7 million, up 13% year on year. This result beat analysts’ expectations by 1.7%. It was a satisfactory quarter as it also put up a decent beat of analysts’ adjusted operating income estimates. The stock is down 5.6% since reporting and currently trades at $41.75. Read our full, actionable report on Steven Madden here, it’s free. Market Update Thanks to the Fed's series of rate hikes in 2022 and 2023, inflation has cooled significantly from its post-pandemic highs, drawing closer to the 2% goal. This disinflation has occurred without severely impacting economic growth, suggesting the success of a soft landing. The stock market thrived in 2024, spurred by recent rate cuts (0.5% in September and 0.25% each in November and December), and a notable surge followed Donald Trump's presidential election win in November, propelling indices to historic highs. Nonetheless, the outlook for 2025 remains clouded by the pace and magnitude of future rate cuts as well as potential changes in trade policy and corporate taxes once the Trump administration takes over. The path forward is marked by uncertainty. Want to invest in winners with rock-solid fundamentals? Check out our Top 6 Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Join Paid Stock Investor Research Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here. View Comments
Unpacking Q3 Earnings: Skechers (NYSE:SKX) In The Context Of Other Footwear Stocks
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...